|
|
| Ranbaxy Laboratories Limited |
|
Financials-Ranbaxy Laboratories Limited| Sector: Bulk Drugs and Formulations | | BSE:359 | NSE:RANBAXY | Bloomberg:RBXY@IN | Reuters:RANB.BO | | Market Lot: 1 | Face Value: 5 | ISIN Demat: INE015A01028 |
|
|
| |
| Financials (Standalone) |
|
|
|
|
../financials/latestHalf.php
| Latest Quarterly/Halfyearly |
|
| As On(Months) |
31-Dec-2014(3) |
31-Dec-2013(3) |
% Change |
| Sales of Products/Services |
9565.16 |
13276.38 |
-27.95 |
| Other Operating Income |
533.33 |
389.25 |
37.01 |
| Other Income |
177.53 |
205.99 |
-13.82 |
| Total Income |
10276.02 |
13871.62 |
-25.92 |
| Total Expenses |
13613.50 |
14326.10 |
-4.97 |
| OPBDIT |
-3337.48 |
-454.48 |
634.35 |
| Interest |
1493.05 |
1183.88 |
26.11 |
| Depreciation |
548.14 |
458.49 |
19.55 |
| Exceptional & Extraordinary Items |
-272.68 |
-1862.75 |
-85.36 |
| Prior Period Adjustments |
0.00 |
0.00 |
-- |
| Provision for Tax |
8553.50 |
0.00 |
-- |
| After Tax Profit |
-14204.85 |
-3959.60 |
258.74 |
| Equity Capital |
2122.44 |
2115.48 |
0.33 |
| Reserves |
0.00 |
0.00 |
-- |
| Notes to Accounts |
|
Click here |
|
|
| As on( Months ) |
31-Dec-07(12) |
|
31-Dec-06(12) |
|
31-Dec-05(12) |
|
| Profit / Loss A/C |
Rs mn |
%OI |
Rs mn |
%OI |
Rs mn |
%OI |
| Net Sales |
41905.29 |
96.66 |
40868.44 |
97.79 |
34340.66 |
96.93 |
| Operating Income (OI) |
43354.62 |
100.00 |
41790.75 |
100.00 |
35427.32 |
100.00 |
| OPBDIT |
4262.14 |
9.83 |
6431.70 |
15.39 |
2070.33 |
5.84 |
| OPBDT |
8491.55 |
19.59 |
5265.15 |
12.60 |
2338.67 |
6.60 |
| OPBT |
7304.24 |
16.85 |
4197.65 |
10.04 |
1325.34 |
3.74 |
| Non-Operating Income |
439.82 |
1.01 |
232.11 |
0.56 |
576.00 |
1.63 |
| Extraordinary/Prior Period |
-1376.44 |
-3.17 |
-527.61 |
-1.26 |
447.55 |
1.26 |
| Tax |
190.42 |
0.44 |
-49.12 |
-0.12 |
228.47 |
0.64 |
| Profit after tax(PAT) |
6177.20 |
14.25 |
3951.27 |
9.45 |
2120.42 |
5.99 |
| Cash Profit |
7364.51 |
16.99 |
5018.77 |
12.01 |
3133.75 |
8.85 |
| Dividend-Equity |
3171.54 |
7.32 |
3168.94 |
7.58 |
3166.66 |
8.94 |
|
| As on |
31-Dec-07 |
|
31-Dec-06 |
|
31-Dec-05 |
|
| Assets |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Gross Block |
20657.12 |
26.53 |
19685.66 |
28.68 |
16493.10 |
35.85 |
| Net Block |
13937.03 |
17.90 |
13732.37 |
20.01 |
11392.94 |
24.77 |
| Capital WIP |
3274.20 |
4.20 |
3018.79 |
4.40 |
4328.43 |
9.41 |
| Investments |
32371.40 |
41.57 |
26795.34 |
39.04 |
7627.75 |
16.58 |
| Inventory |
9760.71 |
12.53 |
9549.12 |
13.91 |
8909.33 |
19.37 |
| Receivables |
8829.06 |
11.34 |
10137.45 |
14.77 |
8066.18 |
17.53 |
| Other Current Assets |
9703.39 |
12.46 |
5398.69 |
7.87 |
5678.17 |
12.34 |
| Balance Sheet Total(BT) |
77875.79 |
100.00 |
68631.76 |
100.00 |
46002.80 |
100.00 |
| Liabilities |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Equity Share Capital |
1865.35 |
2.40 |
1863.43 |
2.72 |
1862.21 |
4.05 |
| Reserves |
22748.63 |
29.21 |
21019.97 |
30.63 |
21301.24 |
46.30 |
| Total Debt |
35030.28 |
44.98 |
31786.00 |
46.31 |
10298.04 |
22.39 |
| Creditors and Acceptances |
5425.05 |
6.97 |
4708.60 |
6.86 |
5704.67 |
12.40 |
| Other current liab/prov. |
12806.48 |
16.44 |
9253.76 |
13.48 |
6836.64 |
14.86 |
| Balance Sheet Total(BT) |
77875.79 |
100.00 |
68631.76 |
100.00 |
46002.80 |
100.00 |
|
| As on |
31-Dec-07 |
31-Dec-06 |
31-Dec-05 |
| OPBIT/Prod.cap.empl.(%) |
12.81 |
21.59 |
4.92 |
| PBIT/Cap. Employed (%) |
3.79 |
9.81 |
7.14 |
| PAT/Networth (%) |
25.10 |
17.27 |
9.15 |
| Tax/PBT (%) |
2.99 |
-1.26 |
9.73 |
| Total Debt/Networth (x) |
1.42 |
1.39 |
0.44 |
| Long Term Debt/Networth (x) |
0.93 |
0.96 |
0.07 |
| PBDIT/Finance Charges (x) |
-0.79 |
5.26 |
-11.53 |
| Current Ratio (x) |
1.55 |
1.80 |
1.81 |
| RM Inventory (days consumption) |
150.50 |
156.95 |
169.03 |
| FG inventory (days cost of sales) |
31.99 |
35.70 |
33.16 |
| Receivables (days gross sales) |
75.97 |
89.36 |
83.63 |
| Creditors (days cost of sales) |
50.65 |
48.61 |
62.42 |
| Op. curr. assets (days OI) |
227.00 |
216.00 |
229.00 |
|
|
Financials